AbbVie Inc. Quarterly Return On Equity in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
AbbVie Inc. quarterly/annual Return On Equity history and growth rate from Q3 2019 to Q2 2024.
  • AbbVie Inc. Return On Equity for the quarter ending June 30, 2024 was 57.1 %, a 2.16% decline year-over-year.
  • AbbVie Inc. annual Return On Equity for 2023 was 39.9 %, a 45.8% decline from 2022.
  • AbbVie Inc. annual Return On Equity for 2022 was 73.6 %, a 11.8% decline from 2021.
  • AbbVie Inc. annual Return On Equity for 2021 was 83.4 %, a 61.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 57.1 -1.26 -2.16% Apr 1, 2024 Jun 30, 2024
Q1 2024 55.1 +5.65 +11.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 39.9 -33.7 -45.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 46.9 -39 -45.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 58.4 -25.9 -30.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 49.5 -36.7 -42.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 73.6 -9.81 -11.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 85.9 +29 +51% Jul 1, 2022 Sep 30, 2022
Q2 2022 84.2 +35.5 +72.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 86.2 +49.9 +137% Jan 1, 2022 Mar 31, 2022
Q4 2021 83.4 +31.7 +61.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 56.9 -148 -72.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 48.7 +355 Apr 1, 2021 Jun 30, 2021
Q1 2021 36.3 +141 Jan 1, 2021 Mar 31, 2021
Q4 2020 51.7 +148 Oct 1, 2020 Dec 31, 2020
Q3 2020 205 +244 Jul 1, 2020 Sep 30, 2020
Q2 2020 -306 Apr 1, 2020 Jun 30, 2020
Q1 2020 -104 Jan 1, 2020 Mar 31, 2020
Q4 2019 -96.2 Oct 1, 2019 Dec 31, 2019
Q3 2019 -39.4 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.